OCONNELL MAUREEN

CIK 00011113185 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001111318

Recent Transactions

50 trades

Award
REV Group, Inc.$REVG
Common Stock
2025-12-03+2,105→ 15,539 total
Award
ACACIA RESEARCH CORP$ACTG
ACTG Common Stock
2025-05-30+32,172→ 272,603 total
Award
REV Group, Inc.$REVG
Common Stock
2024-12-05+3,611→ 13,434 total
Award
ACACIA RESEARCH CORP$ACTG
ACTG Common Stock
2024-06-07+23,121→ 240,431 total
Award
REV Group, Inc.$REVG
Common Stock
2023-12-08+7,084→ 9,823 total
Award
REV Group, Inc.$REVG
Common Stock
2023-08-25+2,739→ 2,739 total
Award
ACACIA RESEARCH CORP$ACTG
ACTG Common Stock
2023-05-26+30,534→ 217,310 total
Award
ACACIA RESEARCH CORP$ACTG
ACTG Common Stock
2022-05-09+26,201→ 186,776 total
Award
ACACIA RESEARCH CORP$ACTG
ACTG Common Stock
2021-05-10+21,661→ 160,575 total
Purchase
ACACIA RESEARCH CORP$ACTG
ACTG Common Stock
2020-09-08$3.77/sh+13,470→ 138,914 total
Purchase
ACACIA RESEARCH CORP$ACTG
ACTG Common Stock
2020-09-04$3.78/sh+11,530→ 125,444 total
Exercise/Conversion
HARTE HANKS INC$HHS
Restricted Stock Units
2020-07-22−4,557→ 0 total
Exercise/Conversion
HARTE HANKS INC$HHS
Common Stock
2020-07-22+4,557→ 29,971 total
Award
ACACIA RESEARCH CORP$ACTG
ACTG Common Stock
2020-06-02+48,000→ 113,914 total
Exercise/Conversion
HARTE HANKS INC$HHS
Restricted Stock Units
2020-03-21−23,136→ 0 total
Exercise/Conversion
HARTE HANKS INC$HHS
Common Stock
2020-03-21+23,136→ 25,414 total
Award
ACACIA RESEARCH CORP$ACTG
ACTG Common Stock
2019-07-30+43,478→ 65,914 total
Award
ACACIA RESEARCH CORP$ACTG
ACTG Common Stock
2019-05-08+22,436→ 22,436 total
Award
HARTE HANKS INC$HHS
Common Stock
2019-03-21+23,136→ 29,971 total
Award
HARTE HANKS INC$HHS
Common Stock
2018-07-27+6,835→ 6,835 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Director Stock Option (right to buy)
2018-02-13$7.70/sh−10,000→ 0 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Director Stock Option (right to buy)
2018-02-13$12.81/sh−30,000→ 0 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Director Stock Option (right to buy)
2018-02-13$1.77/sh−20,000→ 0 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A
2018-02-13$18.00/sh−5,130→ 0 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Director Stock Option (right to buy)
2018-02-13$11.20/sh−20,000→ 0 total
Disposition to Issuer
Sucampo Pharmaceuticals, Inc.
Director Stock Option (right to buy)
2018-02-13$9.38/sh−20,000→ 0 total
Tax Payment
SCHOLASTIC CORP$SCHL
Common Stock
2017-09-25$36.28/sh−800→ 31,121 total
Tax Payment
SCHOLASTIC CORP$SCHL
Common Stock
2017-09-21$35.17/sh−622→ 31,921 total
Tax Payment
SCHOLASTIC CORP$SCHL
Common Stock
2017-09-20$38.61/sh−692→ 32,543 total
Award
SCHOLASTIC CORP$SCHL
Common Stock
2017-09-19$38.60/sh+5,440→ 33,235 total
Award
SCHOLASTIC CORP$SCHL
Employee stock option (right to buy)
2017-09-19+46,936→ 46,936 total
Tax Payment
SCHOLASTIC CORP$SCHL
Common Stock
2017-09-18$39.04/sh−898→ 27,795 total
Exercise/Conversion
SCHOLASTIC CORP$SCHL
Common Stock
2017-09-05$39.34/sh+5,028→ 31,168 total
Tax Payment
SCHOLASTIC CORP$SCHL
Common Stock
2017-09-05$39.34/sh−2,475→ 28,693 total
Exercise/Conversion
SCHOLASTIC CORP$SCHL
Restricted Stock Units
2017-09-05$23.79/sh−5,028→ 0 total
Award
SCHOLASTIC CORP$SCHL
Restricted Stock Units
2017-09-01$28.76/sh+4,954→ 4,954 total
Tax Payment
SCHOLASTIC CORP$SCHL
Common Stock
2017-08-03$40.64/sh−1,725→ 26,140 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock
2017-06-01+5,130→ 14,930 total
Award
Sucampo Pharmaceuticals, Inc.
Director Stock Option (right to buy)
2017-06-01+10,000→ 100,000 total
Sale
SCHOLASTIC CORP$SCHL
Common Stock
2017-01-04$47.45/sh−8,264→ 27,865 total
Sale
SCHOLASTIC CORP$SCHL
Common Stock
2016-12-20$48.08/sh−9,597→ 36,129 total
Exercise/Conversion
SCHOLASTIC CORP$SCHL
Common Stock
2016-12-20$33.87/sh+9,597→ 45,726 total
Sale
SCHOLASTIC CORP$SCHL
Common Stock
2016-12-20$48.32/sh−4,521→ 36,129 total
Exercise/Conversion
SCHOLASTIC CORP$SCHL
Employee stock option (right to buy)
2016-12-20−9,597→ 21,194 total
Exercise/Conversion
SCHOLASTIC CORP$SCHL
Common Stock
2016-12-19$30.17/sh+11,645→ 57,799 total
Sale
SCHOLASTIC CORP$SCHL
Common Stock
2016-12-19$48.01/sh−11,597→ 46,154 total
Exercise/Conversion
SCHOLASTIC CORP$SCHL
Employee Stock Option (right to buy)
2016-12-19−11,645→ 11,645 total
Sale
SCHOLASTIC CORP$SCHL
Common Stock
2016-12-19$47.97/sh−5,479→ 40,675 total
Exercise/Conversion
SCHOLASTIC CORP$SCHL
Common Stock
2016-12-19$33.87/sh+11,597→ 57,751 total
Exercise/Conversion
SCHOLASTIC CORP$SCHL
Employee stock option (right to buy)
2016-12-19−11,597→ 30,791 total

OCONNELL MAUREEN

Recent Transactions

Companies

Recent Filings

Address